Vivani Medical Stock (NASDAQ:VANI)

Revenue Ownership Financials Chart

Previous Close

$1.61

52W Range

$0.91 - $1.80

50D Avg

$1.28

200D Avg

$1.20

Market Cap

$94.79M

Avg Vol (3M)

$110.31K

Beta

3.26

Div Yield

-

VANI Company Profile

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

37

IPO Date

Nov 19, 2014

Website

VANI Performance

VANI Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	-	-	-
Operating Income	$-26.96M	$-21.24M	$-13.32M
Net Income	$-25.65M	$-6.54M	$-12.13M
EBITDA	$-26.61M	$-19.16M	$-12.98M
Basic EPS	$-0.50	$-0.17	$-1.10
Diluted EPS	$-0.50	$-0.17	$-1.10

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q4 19Mar 19, 20 | 4:30 PM

Q3 19Nov 15, 19 | 4:30 PM

Q2 19Aug 07, 19 | 4:30 PM

Peer Comparison

Ticker	Company
CADL	Candel Therapeutics, Inc.
APYX	Apyx Medical Corporation
TNON	Tenon Medical, Inc.
RZLT	Rezolute, Inc.
RENB	Renovaro Biosciences Inc.
IVVD	Invivyd, Inc.
VIGL	Vigil Neuroscience, Inc.